The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles

Biomaterials

Volumn 30, Issue 5, 2009, Pages 919-927

  Lee, Ashlynn L Z ^a,b   Wang, Yong ^a   Cheng, Han Yin ^a   Pervaiz, Shazib ^b   Yang, Yi Yan ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Amphiphilic copolymer; Cationic micellar nanoparticles; Co delivery; Herceptin; Paclitaxel

Indexed keywords

AMPHIPHILIC COPOLYMER; CATIONIC MICELLAR NANOPARTICLES; CO-DELIVERY; HERCEPTIN; PACLITAXEL;

AMMONIUM COMPOUNDS; CELL CULTURE; CIVIL AVIATION; COBALT; COPOLYMERIZATION; DYES; ETHYLENE; POLYMERS; SPECTROSCOPIC ANALYSIS; ZETA POTENTIAL;

NANOPARTICLES;

COPOLYMER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NANOPARTICLE; PACLITAXEL; POLY[(N METHYLDIETHENEAMINE SEBACATE) CO [(CHOLESTERYL OXOCARBONYLAMIDOETHYL)METHYLBIS(ETHYLENE)AMMONIUM BROMIDE]SEBACATE]; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; HUMAN CELL; MICELLE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; ZETA POTENTIAL;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; GENES, ERBB-2; HUMANS; NANOPARTICLES; PACLITAXEL; POLYMERS;

EID: 57649124218     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.10.062     Document Type: Article

References (32)

1. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2 (2003) 347-360
2. Wei H., Zhang X.Z., Zhou Y., Cheng S.X., and Zhuo R.X. Self-assembled thermoresponsive micelles of poly(N-isopropylacrylamide-b-methyl methacrylate). Biomaterials 27 (2006) 2028-2034
3. Seow W.Y., Xue J.M., and Yang Y.Y. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials 28 (2007) 1730-1740
4. Lee E.S., Oh K.T., Kim D., Youn Y.S., and Bae Y.H. Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine). J Control Release 123 (2007) 19-26
5. Liu S.Q., Wiradharma N., Gao S.J., Tong Y.W., and Yang Y.Y. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 28 (2007) 1423-1433
6. Yoo H.S., and Park T.G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 96 (2004) 273-283
7. Wang Y.C., Liu X.Q., Sun T.M., Xiong M.H., and Wang J. Functionalized micelles from block copolymer of polyphosphoester and poly(varepsilon-caprolactone) for receptor-mediated drug delivery. J Control Release 128 (2008) 32-40
8. Zhang X.Q., Wang X.L., Zhang P.C., Liu Z.L., Zhuo R.X., Mao H.Q., et al. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. J Control Release 102 (2005) 749-763
9. Chandna P., Saad M., Wang Y., Ber E., Khandare J., Vetcher A.A., et al. Targeted proapoptotic anticancer drug delivery system. Mol Pharm 4 (2007) 668-678
10. Huang G., Zhou Z., Srinivasan R., Penn M.S., Kottke-Marchant K., Marchant R.E., et al. Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets. Biomaterials 29 (2008) 1676-1685
11. Schrama D., Reisfeld R.A., and Becker J.C. Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov 5 (2006) 147-159
12. Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 1 (2001) 118-129
13. Reichert J.M., and Valge-Archer V.E. Development trends for monoclonal antibody cancer therapeutics. Nat Rev Drug Discov 6 (2007) 349-356
14. Wu A.M., and Senter P.D. Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 23 (2005) 1137-1146
15. Allred D.C., Clark G.M., Tandon A.K., Molina R., Tormey D.C., Osborne C.K., et al. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol 10 (1992) 599-605
16. Hynes N.E., and Stern D.F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198 (1994) 165-184
17. Press M.F., Bernstein L., Thomas P.A., Meisner L.F., Zhou J.Y., Ma Y., et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 15 (1997) 2894-2904
18. Nahta R., and Esteva F.J. Herceptin: mechanism of action and resistance. Cancer Lett 232 (2006) 123-138
19. Nahta R., and Esteva F.J. Trastuzumab: triumphs and tribulations. Oncogene 27 (2006) 3637-3643
20. Lee S., Yang W., Lan K.S., Sellappan S., Kloa K., Hortobagyi, et al. Enhanced sensitization to taxol-induced apoptosis by Herceptin pretreatment in ErbB2-overexpressing breast cancer cells. Cancer Res 62 (2002) 5703-5710
21. Baselga J., Norton L., Albanell J., Kim Y.M., and Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 58 (1998) 2825-2831
22. Burstein H.J., Harris L.N., Gelman R., Lester S.C., Nunes R.A., Kaelin C.M., et al. Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol 21 (2003) 46-53
23. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344 (2001) 783-792
24. Gilbert C.W., McGowan E.B., Seery G.B., Black K.S., and Pegram M.D. Targeted prodrug treatment of HER-2-positive breast tumor cells using trastuzumab and paclitaxel linked by A-Z-CINN Linker. J Exp Ther Oncol 3 (2003) 27-35
25. Sun B., Ranganathan B., and Feng S.S. Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 29 (2008) 475-486
26. Wang Y., Gao S., Ye W.H., Yoon H.S., and Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 5 (2006) 791-796
27. Lee A., Wang Y., Ye W.H., Yoon H.S., Chan S.Y., and Yang Y.Y. Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles. Biomaterials 29 (2008) 1224-1232
28. Xu Y.M., Wang L.F., Jia L.T., Qiu X.C., Zhao J., Yu C.J., et al. A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors. J Immunol 173 (2004) 61-67
29. Zelphati O., Wang Y., Kitada S., Reeds J.C., Felgner P.L., and Corbeil J. Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem 276 (2001) 35103-35110
30. Zheng X., Lunberg M., Karlsson A., and Johansson M. Lipid-mediated protein delivery of suicide nucleoside kinases. Cancer Res 63 (2003) 6909-6913
31. Boyle D.L., Carman P., and Takemoto L. Translocation of macromolecules into whole rat lenses in culture. Mol Vis 8 (2002) 226-234
32. McCabe A., Dolled-Filhart M., Camp R.L., and Rimm D.L. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst 97 (2005) 1808-1815